JWJT CONSULTANCY LTD

Company number 14528539 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

JWJT CONSULTANCY LTD - Analysis Report

Company Number: 14528539

Analysis Date: 2025-07-29 12:57 UTC

Financial Health Assessment for JWJT CONSULTANCY LTD


1. Financial Health Score: B

Explanation:
JWJT Consultancy Ltd displays a solid financial footing typical for a micro-entity in its initial years of operation. The company maintains positive net current assets and shareholders' funds, indicating good liquidity and equity health. However, the relatively modest scale of operations and limited financial history temper a top-tier rating. The "B" grade reflects a generally healthy financial status with room for growth and strengthening of financial resilience.


2. Key Vital Signs

Metric Value (£) Interpretation
Current Assets 11,571 Adequate short-term resources available to meet obligations.
Current Liabilities 6,425 Debts due within a year; manageable relative to assets.
Net Current Assets 5,146 Positive working capital, indicating healthy liquidity.
Net Assets 4,456 Represents total equity; positive figure signals company value.
Shareholders’ Funds 4,456 Equity belonging to owners; positive and consistent.
Average Employees 1 Micro entity size; lean operations.
Filing Status Up to date Compliance with statutory deadlines; no overdue filings.

Interpretation:
The company has a "healthy cash flow" stance as indicated by positive net current assets, meaning it has enough liquid resources to cover short-term debts. Shareholders’ funds being positive reflects retained earnings or capital contributions supporting company solvency. Being a micro entity, the scale is small but stable, reflecting early stage or boutique consultancy operations.


3. Diagnosis

JWJT Consultancy Ltd is operating in the management consultancy sector (SIC 70229) with a lean structure (1 employee, 2 directors). Its financial "vital signs" show no symptoms of distress such as negative working capital or equity erosion. The company has a positive balance sheet with net assets exceeding liabilities, indicating no immediate solvency concerns.

The absence of audit requirements and micro entity reporting provisions means financial statements are concise, but this also limits detailed insights into profitability and cash flows. The company is in its second year, so growth trajectory and operational scalability are not yet fully evident but initial financial health is sound.

The controlling shareholder/director (Mr Jake Turner) has full ownership and voting control, which typically results in streamlined decision-making but also concentration risk.


4. Recommendations

To enhance financial wellness and future-proof the company, consider the following actions:

  • Monitor and build cash reserves: Maintain or increase positive net current assets to cushion against unexpected expenses or market downturns.
  • Plan for growth: Develop a strategic plan for client acquisition to increase turnover, which will improve profitability and net assets.
  • Diversify leadership roles: While currently lean, consider involving additional directors or advisors to mitigate concentration risk and bring diverse expertise.
  • Maintain compliance rigor: Continue timely filing of accounts and confirmation statements to avoid penalties and reputational risks.
  • Explore audit exemption impacts: As the company grows, evaluate whether moving beyond micro entity status and obtaining audits could add credibility with larger clients or lenders.
  • Financial record-keeping: Ensure accurate and detailed accounting records to support future financing or expansion plans.
  • Risk management: Identify any sector-specific risks in consultancy services and put in place mitigation strategies.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.